• Teragezza® is a monophasic combined oral contraceptive (COC) containing 2000mcg cyproterone acetate and 35mcg ethinylestradiol1
  • Each pack of Teragezza® contains 3 x blister strips of 21 tablets for 3 cycles of contraceptive cover1

Please refer to the full Summary of Product Characteristics before prescribing.
Summary of Product Characteristics and Patient Information Leaflet
Summary of Product Characteristics:

Patient Information Leaflet:

Risk Minimisation Materials
Additional Prescriber Resources
The full NICE Clinical Knowledge Summary for contraceptive prescribing for combined oral contraceptives, including UK Medical Eligibility Criteria may be found here.


  1. Morningside Healthcare Ltd. Teragezza 2000/35 microgram Film-coated Tablets. Summary of Product Characteristics. December 2019. Available at: https://www.medicines.org.uk/emc/product/9760/smpc (accessed June 2020).